Discontinued
TENOFOVIR / EMTRICITABINE SANDOZ 301/200 tenofovir disoproxil succinate / emtricitabine 301 mg/200 mg film-coated tablet bottle
emtricitabine~tenofovir disoproxil succinate · 200 mg~300.6 mg Tablet, film coated
- Deletion from market
- 20 May 2026
- TGA row last updated
- 30 July 2026
- ARTG ID
- 326237
- Sponsor
- Sandoz Pty Ltd
- Sponsor phone
- 1800726369
- Shortage impact
- Low
- Availability
- Unavailable
Reason reported to TGA
Manufacturing
TGA management action
This product is being replaced by TENOFOVIR/EMTRICITABINE SANDOZ PHARMA 300/200 tenofovir disoproxil fumarate 300 mg and emtricitabine 200 mg tablet bottle pack (ARTG 475545). Alternative brands are available to cover for any gaps in supply.
What to do
- 1.This product is discontinued in the TGA export — Ask your prescriber or pharmacist about a product that is still supplied. Do not stop treatment without that advice.
Official sources
Last updated from the TGA Medicine Shortage Reports Database (report generated 12 November 2026 10:15:07 PM).
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.